QQQ   419.63 (-0.89%)
AAPL   165.60 (-0.86%)
MSFT   402.53 (-0.43%)
META   489.57 (-2.44%)
GOOGL   155.31 (-0.45%)
AMZN   176.52 (-1.51%)
TSLA   149.91 (-0.01%)
NVDA   825.35 (-2.52%)
AMD   151.82 (-2.10%)
NIO   3.86 (-3.50%)
BABA   68.75 (-0.19%)
T   16.31 (-0.12%)
F   12.13 (+0.58%)
MU   108.96 (-2.65%)
GE   150.99 (-1.28%)
CGC   7.72 (-1.40%)
DIS   111.81 (-0.55%)
AMC   3.12 (+6.85%)
PFE   25.64 (+0.98%)
PYPL   62.01 (-0.14%)
XOM   120.18 (+1.40%)
QQQ   419.63 (-0.89%)
AAPL   165.60 (-0.86%)
MSFT   402.53 (-0.43%)
META   489.57 (-2.44%)
GOOGL   155.31 (-0.45%)
AMZN   176.52 (-1.51%)
TSLA   149.91 (-0.01%)
NVDA   825.35 (-2.52%)
AMD   151.82 (-2.10%)
NIO   3.86 (-3.50%)
BABA   68.75 (-0.19%)
T   16.31 (-0.12%)
F   12.13 (+0.58%)
MU   108.96 (-2.65%)
GE   150.99 (-1.28%)
CGC   7.72 (-1.40%)
DIS   111.81 (-0.55%)
AMC   3.12 (+6.85%)
PFE   25.64 (+0.98%)
PYPL   62.01 (-0.14%)
XOM   120.18 (+1.40%)
QQQ   419.63 (-0.89%)
AAPL   165.60 (-0.86%)
MSFT   402.53 (-0.43%)
META   489.57 (-2.44%)
GOOGL   155.31 (-0.45%)
AMZN   176.52 (-1.51%)
TSLA   149.91 (-0.01%)
NVDA   825.35 (-2.52%)
AMD   151.82 (-2.10%)
NIO   3.86 (-3.50%)
BABA   68.75 (-0.19%)
T   16.31 (-0.12%)
F   12.13 (+0.58%)
MU   108.96 (-2.65%)
GE   150.99 (-1.28%)
CGC   7.72 (-1.40%)
DIS   111.81 (-0.55%)
AMC   3.12 (+6.85%)
PFE   25.64 (+0.98%)
PYPL   62.01 (-0.14%)
XOM   120.18 (+1.40%)
QQQ   419.63 (-0.89%)
AAPL   165.60 (-0.86%)
MSFT   402.53 (-0.43%)
META   489.57 (-2.44%)
GOOGL   155.31 (-0.45%)
AMZN   176.52 (-1.51%)
TSLA   149.91 (-0.01%)
NVDA   825.35 (-2.52%)
AMD   151.82 (-2.10%)
NIO   3.86 (-3.50%)
BABA   68.75 (-0.19%)
T   16.31 (-0.12%)
F   12.13 (+0.58%)
MU   108.96 (-2.65%)
GE   150.99 (-1.28%)
CGC   7.72 (-1.40%)
DIS   111.81 (-0.55%)
AMC   3.12 (+6.85%)
PFE   25.64 (+0.98%)
PYPL   62.01 (-0.14%)
XOM   120.18 (+1.40%)
Free Trial
NASDAQ:ISO

IsoPlexis (ISO) Stock Price, News & Analysis

→ New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad)
Free ISO Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$0.76
▼
$0.76
50-Day Range
$0.74
▼
$1.13
52-Week Range
$0.60
▼
$5.10
Volume
N/A
Average Volume
68,375 shs
Market Capitalization
$30.28 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
ISO stock logo

About IsoPlexis Stock (NASDAQ:ISO)

IsoPlexis Corporation, a life sciences company, provides solutions for the development of curative medicines and personalized therapeutics in the United States, Canada, the United Kingdom, Belgium, France, the Czech Republic, Spain, Germany, Sweden, Italy, Israel, Switzerland, China and Taiwan, Singapore, Japan, Australia, and Korea. The company offers single cell proteomics platform, including instruments, chip consumables, and software that provides an end-to-end solution to view of protein function at an individual cellular level. It provides IsoLight and IsoSpark instruments; IsoCode chips that offer multiplexed chip solutions for single cell functional proteomics; CodePlex chips that provide multiplexed solutions for ultra-low volume bulk samples; and IsoSpeak software that offers dimensional data and automates analysis with an intuitive push button user interface to deliver same day single cell and bulk proteome visualizations, as well as research support and services, and post-warranty services. The company was incorporated in 2013 and is based in Branford, Connecticut.

ISO Stock News Headlines

March 5, 2024 | uk.finance.yahoo.com
Diagnostic Industry Revelations: Comprehensive Analysis of Global Distribution Deals from 2016 to 2024 Unveiled
August 18, 2023 | msn.com
Bruker to buy cell biology company PhenomeX for $108m
April 19, 2024 | InvestorPlace (Ad)
New crypto project uncovers 2,050% in 65 days
During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.
August 17, 2023 | msn.com
Bruker Enters Functional Single-Cell Biology Research Solutions With PhenomeX Acquisition
August 17, 2023 | msn.com
PhenomeX stock rallies by 137% after buyout offer from Bruker
August 17, 2023 | finance.yahoo.com
Bruker Corporation and PhenomeX Inc. Announce Definitive Agreement for Bruker to Acquire PhenomeX in All-Cash Transaction
August 14, 2023 | markets.businessinsider.com
PhenomeX Reports Second Quarter 2023 Financial Results and Provides Business Update
August 11, 2023 | thestreet.com
IsoPlexis Corporation
April 19, 2024 | InvestorPlace (Ad)
New crypto project uncovers 2,050% in 65 days
During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.
May 16, 2023 | marketwatch.com
10-Q: PHENOMEX INC.
May 12, 2023 | finanznachrichten.de
PhenomeX Reports First Quarter 2023 Financial Results
May 5, 2023 | marketwatch.com
Single Cell Proteomics System Market Insights, Forecast to 2029 Market Size 2023-2031 Industrial Regions by Absolute Reports | with [90 Pages]
May 3, 2023 | marketwatch.com
Single Cell Proteomics Analysis System Market Insights, Forecast to 2029 Market Size and volume sale report 2023
April 14, 2023 | marketwatch.com
Tabula Rasa HealthCare Removes Interim Tag, Names Brian Adams CEO
March 21, 2023 | finance.yahoo.com
PhenomeX Strengthens Commercial Leadership Team
February 18, 2023 | finance.yahoo.com
IsoPlexis Corporation (ISO) Stock Historical Prices & Data - Yahoo Finance
February 9, 2023 | finance.yahoo.com
IsoPlexis Corporation's (NASDAQ:ISO) recent US$6.3m market cap decline means a loss of US$65k for insiders who bought this year
February 4, 2023 | benzinga.com
SHAREHOLDER ALERT: Weiss Law Investigates IsoPlexis Corporation
January 15, 2023 | finanznachrichten.de
IsoPlexis Corporation: Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology Company
January 12, 2023 | benzinga.com
IsoPlexis Granted U.S. Patent Titled 'METHODS OF USING NUCLEOTIDE ANALOGUES'
January 12, 2023 | msn.com
IsoPlexis expects FY22 revenue to be below consensus
January 12, 2023 | finance.yahoo.com
IsoPlexis Reports Preliminary Full Year 2022 Revenue
January 10, 2023 | msn.com
Berkeley Lights' Preliminary 2022 Results Deficient, Analysts Say All Eyes On IsoPlexis Execution
January 5, 2023 | msn.com
Morgan Stanley Maintains Equal-Weight Rating for IsoPlexis: Here's What You Need To Know
December 23, 2022 | barrons.com
Thinking about buying stock in Mullen Automotive, Cleveland-Cliffs, CarMax, IsoPlexis, or Teva Pharmaceutical?
December 23, 2022 | markets.businessinsider.com
Analysts Conflicted on These Technology Names: Workday (WDAY) and IsoPlexis (ISO)
December 23, 2022 | benzinga.com
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating IsoPlexis Corporation Buyout
See More Headlines
Receive ISO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IsoPlexis and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/10/2021
Today
4/18/2024
Fiscal Year End
12/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Analytical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:ISO
CUSIP
N/A
CIK
1615055
Web
isoplexis.com
Phone
203-208-4111
Fax
N/A
Employees
459
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($2.70)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-106,000,000.00
Net Margins
-632.41%
Pretax Margin
-632.40%
Return on Equity
-127.86%
Return on Assets
-71.41%

Debt

Debt-to-Equity Ratio
1.12
Current Ratio
4.06
Quick Ratio
2.50

Sales & Book Value

Annual Sales
$16.76 million
Price / Sales
1.81
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.04 per share
Price / Book
0.73

Miscellaneous

Outstanding Shares
39,760,000
Free Float
37,218,000
Market Cap
$30.28 million
Optionable
Not Optionable
Beta
1.32
Elon Musk's Next Move Cover
Elon Musk's Next Move

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

  • Mr. Sean Mackay (Age 40)
    Co-Founder, CEO, Pres & Director
    Comp: $635.55k
  • Mr. John R. Strahley CPA (Age 55)
    Chief Financial Officer
    Comp: $444.11k
  • Mr. Rong Fan
    Co-Founder & Chairman of Scientific Advisory Board
  • Mr. Jon Chen
    VP of Scientific Alliance Technology & Co-Founder
  • Mr. Anthony Catalano
    Sr. VP of Operations
  • Mr. Rajesh T. Khakhar
    VP of Fin. & Principal Accounting Officer
  • Ms. Jing Zhou M.D. (Age 52)
    Ph.D., Chief Scientific Officer
  • Mr. Richard W. Rew II (Age 54)
    Sr. VP, Gen. Counsel & Sec.
  • Ms. Verna Siu
    Sr. VP of Sales Operations
  • Ms. Carrie Carter
    Sr. VP of People Operations

Key Competitors

View All Competitors

ISO Stock Analysis - Frequently Asked Questions

How were IsoPlexis' earnings last quarter?

IsoPlexis Co. (NASDAQ:ISO) announced its quarterly earnings results on Wednesday, November, 10th. The company reported ($10.66) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.79) by $9.87. The firm had revenue of $4.19 million for the quarter, compared to analysts' expectations of $3.79 million. IsoPlexis had a negative trailing twelve-month return on equity of 127.86% and a negative net margin of 632.41%.

When did IsoPlexis IPO?

IsoPlexis (ISO) raised $125 million in an IPO on Friday, October 8th 2021. The company issued 8,333,000 shares at $14.00-$16.00 per share.

This page (NASDAQ:ISO) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden’s $374B Giveaway Into This Sector
DTI
Your Money is Not Safe
American Alternative
The #1 Crypto for 2024
InvestorPlace
He Is Giving Away Bitcoin
Crypto Swap Profits
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
Urgent alert: open this for a huge profit potential
Timothy Sykes